Combination of pre-existing atrial fibrillation and coronary artery disease associates with poor outcome in patients who undergo TAVI
Event: ESC Congress 2017
Topic: Aortic valve disease
Session: Risk stratification and prognosis after TAVI
Do we need antiplatelet therapy before transcatheter aortic valve implantation?
Event: ESC Congress 2016
Topic: Surgery and intervention in valve disease
Session: Aortic valve disease
ESC 365 is supported by
